Histamine dihydrochloride and low-dose interleukin-2 has antileukemic efficacy in NPM1-mutated and myelomonocytic/monocytic acute myeloid leukemia.
Haematologica
; 2024 Jun 20.
Article
in En
| MEDLINE
| ID: mdl-38899344
ABSTRACT
Not available.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Haematologica
Year:
2024
Document type:
Article
Country of publication:
Italy